You must log in to view this page.

You must log in to view this page.

ADMA Biologics Inc – Filings and Transcripts

NASDAQ: ADMA
Share price (11/6/26): $12.73
Market cap (11/6/26): $2.824 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Grossman Adam S

Grossman Adam S

State Street Corporation

Kestenberg-Messina Kaitlin M.

News Filter

Reports Third Quarter 2026 Financial Results and Provides Business Update

Reports Second Quarter 2026 Financial Results and Provides Business Update

Shareholder Vote Results

Reports First Quarter 2026 Financial Results and Provides Business Update

Announces FDA Approval to Expand the Label for ASCENIVTM to Include Pediatric Immune Compromised Patients Two Years of Age and Older

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC